Wednesday, December 3, 2008 - 1:01AM EST

Stem Cell Transplantation

11. Allogeneic hematopoietic stem cell transplantation in pediatric chronic myelogenous leukemia cases: Hacettepe experience.

Author
Unal S; Fidan G; Tavil B; Cetin M; Cetinkaya DU;
Institution
Division of Pediatric Hematology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Sihhiye, Ankara, Turkey. suleunal2003@hotmail.com
Journal
Pediatr Transplant. 2007 Sep;11(6):645-9.
Abstract URL
Click here to view abstract

12. Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity.

Author
Jabbour E; Cortes J; Kantarjian H; Giralt S; Andersson BS; Giles F; Shpall E; Kebriaei P; Champlin R; de Lima M;
Institution
Department of Blood and Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Journal
Cancer. 2007 Jul 15;110(2):340-4.
Abstract URL
Click here to view abstract

13. Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature.

Author
Liu FC; Chen CH; Chao TY;
Institution
Divisions of Rheumatology/Immunology/Allergy, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan, Republic of China.
Journal
Clin Rheumatol. 2007 Jul;26(7):1207-10. Epub 2006 Aug 26.
Abstract URL
Click here to view abstract

14. Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.

Author
Kebriaei P; Detry MA; Giralt S; Carrasco-Yalan A; Anagnostopoulos A; Couriel D; Khouri IF; Anderlini P; Hosing C; Alousi A; Champlin RE; de Lima M;
Institution
Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. pkebriaei@mdanderson.org
Journal
Blood. 2007 Nov 1;110(9):3456-62. Epub 2007 Jul 25.
Abstract URL
Click here to view abstract

15. Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy.

Author
Weisser M; Schleuning M; Haferlach C; Schwerdtfeger R; Kolb HJ;
Institution
Department of Medicine III, Klinikum Grosshadern, Ludwig Maximilians University of Munich, Germany. martin.weisser@gmx.de
Journal
Leuk Lymphoma. 2007 Feb;48(2):295-301.
Abstract URL
Click here to view abstract

16. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.

Author
Simon W; Segel GB; Lichtman MA;
Institution
Department of Biochemistry and Biophysics, University of Rochester School of Medicine, NY 14642, USA.
Journal
Blood Cells Mol Dis. 2006 Sep-Oct;37(2):116-24; discussion 125-7. Epub 2006 Aug 10.
Abstract URL
Click here to view abstract

17. Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia.

Author
Krejci M; Mayer J; Doubek M; Brychtova Y; Pospisil Z; Racil Z; Dvorakova D; Lengerova M; Horky O; Koristek Z; Dolezal T; Vorlicek J;
Institution
Department of Internal Medicine - Hematooncology, University Hospital Brno, Brno, Czech Republic.
Journal
Bone Marrow Transplant. 2006 Oct;38(7):483-91. Epub 2006 Aug 28.
Abstract URL
Click here to view abstract
Pages: 1 2 3